Optimizing drug discovery in a fast-moving market

Biopharmaceutical Medicine is one of the significant pioneering sectors of modern times. Owing to ongoing innovation in the field, new cutting-edge biologics-based drugs can now address many diseases and illnesses that were untreatable just a few years ago. Spanning several stages, from target identification and assay development to screening and lead optimization, the path-to-market for newly synthesized biologic drug candidates is undergoing a period of rapid acceleration and optimization. Read about the latest survey results in this rapidly changing market.


Covered in this Article
In 2021, over 200 biopharma executives were surveyed about changing approaches to building biologic drug development pipelines.
Organizations are now considering different approaches, focusing on where and how they conduct their development programs.
This executive summary presents the findings from this outreach.
Share your details to Get the Application Note